<?xml version="1.0" encoding="UTF-8" standalone="no"?><document setID="46c2cb4b-eb65-45f5-891f-5e574adc962d"><labelDrug name="Losartan Potassium"><Normalization><mmtx cui="C0700492" preferredWord="Losartan Potassium" semType="phsu, orch"/></Normalization></labelDrug><generic name="losartan potassium"/><sentence id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.1" text="Drug Label for drug brand Losartan Potassium, containing losartan potassium." type="negative"><entity charOffset="0:19" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.1.e.0" text="drug drug" type="Biomedical_Entity"><Normalization><mmtx cui="C0013231" phraseText="Drug Label for drug brand Losartan Potassium," preferredWord="Drugs, Non-Prescription" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="26:44" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.1.e.1" text="losartan potassium" type="Biomedical_Entity"><Normalization><mmtx cui="C0700492" phraseText="Drug Label for drug brand Losartan Potassium," preferredWord="Losartan Potassium" semType="phsu, orch"/><RxNorm RxCui="52175"/></Normalization></entity><entity charOffset="57:75" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.1.e.2" text="losartan potassium" type="Biomedical_Entity"><Normalization><mmtx cui="C0700492" phraseText="losartan potassium." preferredWord="Losartan Potassium" semType="phsu, orch"/><RxNorm RxCui="52175"/></Normalization></entity><pair ddi="false" e1="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.1.e.0" e2="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.1.e.1"/><pair ddi="false" e1="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.1.e.0" e2="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.1.e.2"/></sentence><sentence id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.7" text="Losartan, administered for 12 days, did not affect the pharmacokinetics or pharmacodynamics of a single dose of warfarin. " type="negative"><entity charOffset="0:8" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.7.e.0" text="losartan" type="Biomedical_Entity"><Normalization><mmtx cui="C0126174" phraseText="Losartan," preferredWord="Losartan" semType="phsu, orch"/><RxNorm RxCui="52175"/></Normalization></entity><entity charOffset="112:120" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.7.e.1" text="warfarin" type="Biomedical_Entity"><Normalization><mmtx cui="C0043031" phraseText="pharmacodynamics of a single dose of warfarin." preferredWord="Warfarin" semType="phsu, orch, hops"/><RxNorm RxCui="11289"/></Normalization></entity><pair ddi="false" e1="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.7.e.0" e2="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.7.e.1"/></sentence><sentence id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.8" text="Losartan did not affect the pharmacokinetics of oral or intravenous digoxin. " type="negative"><entity charOffset="0:8" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.8.e.0" text="losartan" type="Biomedical_Entity"><Normalization><mmtx cui="C0126174" phraseText="Losartan" preferredWord="Losartan" semType="phsu, orch"/><RxNorm RxCui="52175"/></Normalization></entity><entity charOffset="68:75" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.8.e.1" text="digoxin" type="Biomedical_Entity"><Normalization><mmtx cui="C0012265" phraseText="intravenous digoxin." preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><pair ddi="false" e1="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.8.e.0" e2="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.8.e.1"/></sentence><sentence id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.9" text="There is no pharmacokinetic interaction between losartan and hydrochlorothiazide. " type="negative"><entity charOffset="61:80" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.9.e.0" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="hydrochlorothiazide." preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="48:56" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.9.e.1" text="losartan" type="Biomedical_Entity"><Normalization><mmtx cui="C0126174" phraseText="no pharmacokinetic interaction between losartan" preferredWord="Losartan" semType="phsu, orch"/><RxNorm RxCui="52175"/></Normalization></entity><pair ddi="false" e1="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.9.e.1" e2="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.9.e.0"/></sentence><sentence biomedicalEntities="2" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.10" lineNumber="12" text="Coadministration of losartan and cimetidine led to an increase of about 18% in AUC of losartan but did not affect the pharmacokinetics of its active metabolite. " type="regular"><entity charOffset="54:62|76:82" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.10.e.1" text="increase in AUC" type="Increase_Interaction"/><entity charOffset="86:94" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.10.e.2" text="losartan" type="Drug"><Normalization><mmtx cui="C0126174" phraseText="of losartan" preferredWord="Losartan" semType="phsu, orch"/><RxNorm RxCui="52175"/></Normalization></entity><entity charOffset="33:43" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.10.e.3" text="cimetidine" type="Drug"><Normalization><mmtx cui="C0008783" phraseText="cimetidine" preferredWord="Cimetidine" semType="phsu, orch"/><RxNorm RxCui="2541"/></Normalization></entity><drugInteraction id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.10.ddi.1"><interaction trigger="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.10.e.1"><relations><relation type="hasObject"><entity id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.10.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.10.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.10.e.3" e2="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.10.e.2" trigger="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.10.e.1" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.11" lineNumber="12" text="Coadministration of losartan and phenobarbital led to a reduction of about 20% in the AUC of losartan and that of its active metabolite. " type="regular"><entity charOffset="56:65|79:89" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.11.e.1" text="reduction in the AUC" type="Decrease_Interaction"/><entity charOffset="93:101" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.11.e.2" text="losartan" type="Drug"><Normalization><mmtx cui="C0126174" phraseText="of losartan" preferredWord="Losartan" semType="phsu, orch"/><RxNorm RxCui="52175"/></Normalization></entity><entity charOffset="33:46" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.11.e.3" text="phenobarbital" type="Drug"><Normalization><mmtx cui="C0031412" phraseText="phenobarbital" preferredWord="Phenobarbital" semType="phsu, orch"/><RxNorm RxCui="8134"/></Normalization></entity><drugInteraction id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.11.ddi.1"><interaction trigger="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.11.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.11.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.11.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.11.e.3" e2="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.11.e.2" trigger="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.11.e.1" type="Decrease_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.12" lineNumber="12" text="A somewhat greater interaction (approximately 40% reduction in the AUC of active metabolite and approximately 30% reduction in the AUC of losartan) has been reported with rifampin. " type="regular"><entity charOffset="114:134" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.12.e.1" text="reduction in the AUC" type="Decrease_Interaction"/><entity charOffset="171:179" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.12.e.2" text="rifampin" type="Drug"><Normalization><mmtx cui="C0035608" phraseText="reported with rifampin." preferredWord="Rifampin" semType="orch, antb"/><RxNorm RxCui="9384"/></Normalization></entity><entity charOffset="138:146" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.12.e.3" text="losartan" type="Drug"><Normalization><mmtx cui="C0126174" phraseText="approximately 30% reduction in the AUC of losartan" preferredWord="Losartan" semType="phsu, orch"/><RxNorm RxCui="52175"/></Normalization></entity><drugInteraction id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.12.ddi.1"><interaction trigger="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.12.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.12.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.12.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.12.e.3" e2="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.12.e.2" trigger="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.12.e.1" type="Decrease_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.13" lineNumber="12" text="Fluconazole, an inhibitor of cytochrome P450 2C9, decreased the AUC of the active metabolite by approximately 40%, but increased the AUC of losartan by approximately 70% following multiple doses. " type="regular"><entity charOffset="16:48" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.13.e.1" text="inhibitor of cytochrome P450 2C9" type="Drug_Class"><Normalization><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="0:11" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.13.e.2" text="Fluconazole" type="Drug"><Normalization><mmtx cui="C0016277" phraseText="Fluconazole," preferredWord="Fluconazole" semType="phsu, orch"/><RxNorm RxCui="4450"/></Normalization></entity><entity charOffset="119:136" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.13.e.4" text="increased the AUC" type="Increase_Interaction"/><entity charOffset="140:148" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.13.e.5" text="losartan" type="Drug"><Normalization><mmtx cui="C0126174" phraseText="the AUC of losartan" preferredWord="Losartan" semType="phsu, orch"/><RxNorm RxCui="52175"/></Normalization></entity><drugClassMembership drug="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.13.e.2" drugClass="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.13.e.1"/><drugInteraction id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.13.ddi.1"><interaction trigger="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.13.e.4"><relations><relation type="hasObject"><entity id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.13.e.5"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.13.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.13.e.2" e2="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.13.e.5" trigger="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.13.e.4" type="Increase_Interaction"/></sentence><sentence id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.14" text="Conversion of losartan to its active metabolite after intravenous administration is not affected by ketoconazole, an inhibitor of P450 3A4. " type="negative"><entity charOffset="14:22" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.14.e.0" text="losartan" type="Biomedical_Entity"><Normalization><mmtx cui="C0126174" phraseText="Conversion of losartan" preferredWord="Losartan" semType="phsu, orch"/><RxNorm RxCui="52175"/></Normalization></entity><entity charOffset="100:112" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.14.e.1" text="ketoconazole" type="Biomedical_Entity"><Normalization><mmtx cui="C0022625" phraseText="affected by ketoconazole," preferredWord="Ketoconazole" semType="phsu, orch"/><RxNorm RxCui="6135"/></Normalization></entity><pair ddi="false" e1="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.14.e.0" e2="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.14.e.1"/></sentence><sentence biomedicalEntities="4" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.15" lineNumber="12" text="The AUC of active metabolite following oral losartan was not affected by erythromycin, another inhibitor of P450 3A4, but the AUC of losartan was increased by 30%." type="regular"><anaphoraRelation><anaphoraEntity charOffset="133:141" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.15.e.3" text="losartan" type="Drug"/><antecedentEntity charOffset="39-52" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.15.e.5" text="oral losartan" type="Drug"/></anaphoraRelation><entity charOffset="126:129|142:155" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.15.e.1" text="AUC was increased" type="Increase_Interaction"/><entity charOffset="73:85" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.15.e.2" text="erythromycin" type="Drug"><Normalization><mmtx cui="C0014806" phraseText="affected by erythromycin," preferredWord="Erythromycin" semType="orch, antb"/><RxNorm RxCui="4053"/></Normalization></entity><entity charOffset="133:141" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.15.e.3" text="losartan" type="Drug"><Normalization><mmtx cui="C0126174" phraseText="the AUC of losartan" preferredWord="Losartan" semType="phsu, orch"/><RxNorm RxCui="52175"/></Normalization></entity><entity charOffset="39:52" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.15.e.5" text="oral losartan" type="Drug"><Normalization><mmtx cui="C0126174" phraseText="oral losartan" preferredWord="Losartan" semType="phsu, orch"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="95:116" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.15.e.7" text="inhibitor of P450 3A4" type="Drug_Class"><Normalization><RxNorm RxCui="NA"/></Normalization></entity><drugClassMembership drug="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.15.e.2" drugClass="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.15.e.7"/><drugInteraction id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.15.ddi.1"><interaction trigger="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.15.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.15.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.15.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.15.e.2" e2="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.15.e.3" trigger="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.15.e.1" type="Increase_Interaction"/></sentence><sentence id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.27" text="Mothers whose embryos and fetuses are exposed to an angiotensin II receptor antagonist only during the first trimester should be so informed. " type="negative"><entity charOffset="52:86" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.27.e.0" text="angiotensin ii receptor antagonist" type="Biomedical_Entity"><Normalization><mmtx cui="C0521942" phraseText="exposed to an angiotensin II receptor antagonist only" preferredWord="Angiotensin II receptor antagonist" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="132:140" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.27.e.1" text="informed" type="Biomedical_Entity"><Normalization><mmtx cui="C0537670" phraseText="informed." preferredWord="Oprelvekin" semType="phsu, aapp, imft"/><RxNorm RxCui="217731"/></Normalization></entity><pair ddi="false" e1="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.27.e.0" e2="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.27.e.1"/></sentence><sentence id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.42" text="In patients who are intravascularly volume-depleted (e.g., those treated with diuretics), symptomatic hypotension may occur after initiation of therapy with losartan potassium tablets. " type="negative"><entity charOffset="157:175" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.42.e.0" text="losartan potassium" type="Biomedical_Entity"><Normalization><mmtx cui="C0700492" phraseText="with losartan potassium tablets." preferredWord="Losartan Potassium" semType="phsu, orch"/><RxNorm RxCui="52175"/></Normalization></entity><entity charOffset="78:87" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.42.e.1" text="diuretics" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="treated with diuretics" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><pair ddi="false" e1="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.42.e.1" e2="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.42.e.0"/></sentence><sentence id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.51" text="As a consequence of inhibiting the renin-angiotensin-aldosterone system, changes in renal function have been reported in susceptible individuals treated with losartan potassium tablets, in some patients, these changes in renal function were reversible upon discontinuation of therapy." type="negative"><entity charOffset="158:176" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.51.e.0" text="losartan potassium" type="Biomedical_Entity"><Normalization><mmtx cui="C0700492" phraseText="treated with losartan potassium tablets," preferredWord="Losartan Potassium" semType="phsu, orch"/><RxNorm RxCui="52175"/></Normalization></entity><entity charOffset="41:52" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.51.e.1" text="angiotensin" type="Biomedical_Entity"><Normalization><mmtx cui="C0003018" phraseText="the renin-angiotensin-aldosterone system," preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="53:64" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.51.e.2" text="aldosterone" type="Biomedical_Entity"><Normalization><mmtx cui="C0002006" phraseText="the renin-angiotensin-aldosterone system," preferredWord="Aldosterone" semType="strd, phsu, horm"/><RxNorm RxCui="1312358"/></Normalization></entity><pair ddi="false" e1="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.51.e.1" e2="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.51.e.0"/><pair ddi="false" e1="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.51.e.2" e2="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.51.e.0"/><pair ddi="false" e1="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.51.e.1" e2="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.51.e.2"/></sentence><sentence id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.52" text="In patients whose renal function may depend on the activity of the renin-angiotensin-aldosterone system (e.g., patients with severe congestive heart failure), treatment with angiotensin converting enzyme inhibitors has been associated with oliguria and/or progressive azotemia and (rarely) with acute renal failure and/or death. " type="negative"><entity charOffset="174:214" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.52.e.0" text="angiotensin converting enzyme inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="treatment with angiotensin converting enzyme inhibitors" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="85:96" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.52.e.1" text="aldosterone" type="Biomedical_Entity"><Normalization><mmtx cui="C0002006" phraseText="depend on the activity of the renin-angiotensin-aldosterone system" preferredWord="Aldosterone" semType="strd, phsu, horm"/><RxNorm RxCui="1312358"/></Normalization></entity><entity charOffset="73:84" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.52.e.2" text="angiotensin" type="Biomedical_Entity"><Normalization><mmtx cui="C0003018" phraseText="depend on the activity of the renin-angiotensin-aldosterone system" preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><pair ddi="false" e1="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.52.e.1" e2="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.52.e.0"/><pair ddi="false" e1="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.52.e.2" e2="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.52.e.0"/><pair ddi="false" e1="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.52.e.2" e2="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.52.e.1"/></sentence><sentence id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.54" text="In studies of ACE inhibitors in patients with unilateral or bilateral renal artery stenosis, increases in serum creatinine or blood urea nitrogen (BUN) have been reported. " type="negative"><entity charOffset="132:136" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.54.e.0" text="urea" type="Biomedical_Entity"><Normalization><mmtx cui="C0041942" phraseText="blood urea nitrogen (BUN)" preferredWord="Urea" semType="bacs, phsu, orch"/><RxNorm RxCui="11002"/></Normalization></entity><entity charOffset="14:28" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.54.e.1" text="ace inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="of ACE inhibitors" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><pair ddi="false" e1="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.54.e.1" e2="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.54.e.0"/></sentence><sentence biomedicalEntities="3" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.62" lineNumber="63" text="Potassium Supplements: A patient receiving losartan potassium tablets should be told not to use potassium supplements or salt substitutes containing potassium without consulting the prescribing physician (see PRECAUTIONS, Drug Interactions)." type="regular"><entity charOffset="85:95" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.62.e.1" text="not to use" type="Caution_Interaction"/><entity charOffset="96:117" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.62.e.2" text="potassium supplements" type="Drug_Class"><Normalization><mmtx cui="C0304475" phraseText="potassium supplements" preferredWord="Potassium supplement" semType="inch, phsu"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="43:61" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.62.e.3" text="losartan potassium" type="Drug"><Normalization><mmtx cui="C0700492" phraseText="A patient receiving losartan potassium tablets" preferredWord="Losartan Potassium" semType="phsu, orch"/><RxNorm RxCui="52175"/></Normalization></entity><entity charOffset="121:158" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.62.e.4" text="salt substitutes containing potassium" type="Substance"><Normalization><mmtx cui="C0784217" phraseText="salt substitutes" preferredWord="Salt Substitute" semType="inch, phsu"/><mmtx cui="C0597277" phraseText="potassium without consulting" preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="9547"/></Normalization></entity><drugInteraction id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.62.ddi.1"><interaction trigger="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.62.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.62.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.62.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.62.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.62.e.3" e2="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.62.e.2" trigger="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.62.e.1" type="Caution_Interaction"/><pair ddi="true" e1="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.62.e.3" e2="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.62.e.4" trigger="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.62.e.1" type="Caution_Interaction"/><pair ddi="false" e1="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.62.e.2" e2="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.62.e.4"/></sentence><sentence id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.63" text="No significant drug-drug pharmacokinetic interactions have been found in interaction studies with hydrochlorothiazide, digoxin, warfarin, cimetidine and phenobarbital. " type="negative"><entity charOffset="128:136" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.63.e.0" text="warfarin" type="Biomedical_Entity"><Normalization><mmtx cui="C0043031" phraseText="warfarin," preferredWord="Warfarin" semType="phsu, orch, hops"/><RxNorm RxCui="11289"/></Normalization></entity><entity charOffset="119:126" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.63.e.1" text="digoxin" type="Biomedical_Entity"><Normalization><mmtx cui="C0012265" phraseText="digoxin," preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><entity charOffset="153:166" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.63.e.2" text="phenobarbital" type="Biomedical_Entity"><Normalization><mmtx cui="C0031412" phraseText="phenobarbital." preferredWord="Phenobarbital" semType="phsu, orch"/><RxNorm RxCui="8134"/></Normalization></entity><entity charOffset="98:117" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.63.e.3" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="studies with hydrochlorothiazide," preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="138:148" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.63.e.4" text="cimetidine" type="Biomedical_Entity"><Normalization><mmtx cui="C0008783" phraseText="cimetidine" preferredWord="Cimetidine" semType="phsu, orch"/><RxNorm RxCui="2541"/></Normalization></entity><pair ddi="false" e1="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.63.e.1" e2="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.63.e.0"/><pair ddi="false" e1="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.63.e.0" e2="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.63.e.2"/><pair ddi="false" e1="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.63.e.3" e2="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.63.e.0"/><pair ddi="false" e1="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.63.e.0" e2="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.63.e.4"/><pair ddi="false" e1="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.63.e.1" e2="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.63.e.2"/><pair ddi="false" e1="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.63.e.3" e2="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.63.e.1"/><pair ddi="false" e1="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.63.e.1" e2="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.63.e.4"/><pair ddi="false" e1="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.63.e.3" e2="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.63.e.2"/><pair ddi="false" e1="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.63.e.4" e2="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.63.e.2"/><pair ddi="false" e1="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.63.e.3" e2="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.63.e.4"/></sentence><sentence biomedicalEntities="2" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.64" lineNumber="64" text="Rifampin, an inducer of drug metabolism, decreased the concentrations of losartan and its active metabolite. " type="regular"><entity charOffset="41:69" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.64.e.1" text="decreased the concentrations" type="Decrease_Interaction"/><entity charOffset="73:81" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.64.e.2" text="losartan" type="Drug"><Normalization><mmtx cui="C0126174" phraseText="the concentrations of losartan" preferredWord="Losartan" semType="phsu, orch"/><RxNorm RxCui="52175"/></Normalization></entity><entity charOffset="0:8" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.64.e.3" text="Rifampin" type="Drug"><Normalization><mmtx cui="C0035608" phraseText="Rifampin," preferredWord="Rifampin" semType="orch, antb"/><RxNorm RxCui="9384"/></Normalization></entity><drugInteraction id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.64.ddi.1"><interaction trigger="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.64.e.1"><relations><relation type="hasObject"><entity id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.64.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.64.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.64.e.3" e2="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.64.e.2" trigger="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.64.e.1" type="Decrease_Interaction"/></sentence><sentence id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.67" text="Ketoconazole did not affect the conversion of losartan to the active metabolite after intravenous administration of losartan, and erythromycin had no clinically significant effect after oral administration. " type="negative"><entity charOffset="46:54" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.67.e.0" text="losartan" type="Biomedical_Entity"><Normalization><mmtx cui="C0126174" phraseText="the conversion of losartan" preferredWord="Losartan" semType="phsu, orch"/><RxNorm RxCui="52175"/></Normalization></entity><entity charOffset="130:142" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.67.e.1" text="erythromycin" type="Biomedical_Entity"><Normalization><mmtx cui="C0014806" phraseText="erythromycin" preferredWord="Erythromycin" semType="orch, antb"/><RxNorm RxCui="4053"/></Normalization></entity><entity charOffset="0:12" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.67.e.2" text="ketoconazole" type="Biomedical_Entity"><Normalization><mmtx cui="C0022625" phraseText="Ketoconazole" preferredWord="Ketoconazole" semType="phsu, orch"/><RxNorm RxCui="6135"/></Normalization></entity><entity charOffset="116:124" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.67.e.3" text="losartan" type="Biomedical_Entity"><Normalization><mmtx cui="C0126174" phraseText="of losartan," preferredWord="Losartan" semType="phsu, orch"/><RxNorm RxCui="52175"/></Normalization></entity><pair ddi="false" e1="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.67.e.0" e2="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.67.e.1"/><pair ddi="false" e1="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.67.e.2" e2="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.67.e.0"/><pair ddi="false" e1="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.67.e.2" e2="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.67.e.1"/><pair ddi="false" e1="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.67.e.3" e2="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.67.e.1"/><pair ddi="false" e1="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.67.e.2" e2="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.67.e.3"/></sentence><sentence biomedicalEntities="3" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.68" lineNumber="64" text="Fluconazole, an inhibitor of P450 2C9, decreased active metabolite concentration and increased losartan concentration. " type="regular"><entity charOffset="16:37" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.68.e.1" text="inhibitor of P450 2C9" type="Drug_Class"><Normalization><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="0:11" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.68.e.2" text="Fluconazole" type="Drug"><Normalization><mmtx cui="C0016277" phraseText="Fluconazole," preferredWord="Fluconazole" semType="phsu, orch"/><RxNorm RxCui="4450"/></Normalization></entity><entity charOffset="85:94|104:117" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.68.e.4" text="increased concentration" type="Increase_Interaction"/><entity charOffset="95:103" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.68.e.5" text="losartan" type="Drug"><Normalization><mmtx cui="C0126174" phraseText="increased losartan concentration." preferredWord="Losartan" semType="phsu, orch"/><RxNorm RxCui="52175"/></Normalization></entity><drugClassMembership drug="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.68.e.2" drugClass="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.68.e.1"/><drugInteraction id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.68.ddi.1"><interaction trigger="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.68.e.4"><relations><relation type="hasPrecipitant"><entity id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.68.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.68.e.5"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.68.e.2" e2="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.68.e.5" trigger="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.68.e.4" type="Increase_Interaction"/></sentence><sentence id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.71" text="These data suggest that the conversion of losartan to its active metabolite is mediated primarily by P450 2C9 and not P450 3A4." type="negative"><entity charOffset="42:50" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.71.e.0" text="losartan" type="Biomedical_Entity"><Normalization><mmtx cui="C0126174" phraseText="the conversion of losartan" preferredWord="Losartan" semType="phsu, orch"/><RxNorm RxCui="52175"/></Normalization></entity><entity charOffset="79:87" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.71.e.1" text="mediated" type="Biomedical_Entity"><Normalization><mmtx cui="C0127400" phraseText="mediated" preferredWord="Mediator brand of benfluorex hydrochloride" semType="phsu, orch"/><RxNorm RxCui="985488"/></Normalization></entity><pair ddi="false" e1="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.71.e.0" e2="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.71.e.1"/></sentence><sentence biomedicalEntities="7" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.72" lineNumber="65" text="As with other drugs that block angiotensin II or its effects, concomitant use of potassium-sparing diuretics (e.g., spironolactone, triamterene, amiloride), potassium supplements, or salt substitutes containing potassium may lead to increases in serum potassium." type="regular"><entity charOffset="81:108" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.72.e.1" text="potassium-sparing diuretics" type="Drug_Class"><Normalization><mmtx cui="C0304490" phraseText="concomitant use of potassium-sparing diuretics" preferredWord="Potassium Sparing Diuretics" semType="phsu"/><RxNorm RxCui="1437061"/></Normalization></entity><entity charOffset="116:130" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.72.e.2" text="spironolactone" type="Drug"><Normalization><mmtx cui="C0037982" phraseText="spironolactone," preferredWord="Spironolactone" semType="strd, phsu"/><RxNorm RxCui="9997"/></Normalization></entity><entity charOffset="132:143" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.72.e.4" text="triamterene" type="Drug"><Normalization><mmtx cui="C0040869" phraseText="triamterene," preferredWord="Triamterene" semType="phsu, orch"/><RxNorm RxCui="10763"/></Normalization></entity><entity charOffset="145:154" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.72.e.6" text="amiloride" type="Drug"><Normalization><mmtx cui="C0002502" phraseText="amiloride" preferredWord="Amiloride" semType="phsu, orch"/><RxNorm RxCui="142424"/></Normalization></entity><entity charOffset="233:261" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.72.e.8" text="increases in serum potassium" type="Specific_Interaction"/><entity charOffset="14:45" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.72.e.9" text="drugs that block angiotensin II" type="Drug_Class"><Normalization><mmtx cui="C0013227" phraseText="As with other drugs" preferredWord="Pharmaceutical Preparations" semType="phsu"/><mmtx cui="C0003009" phraseText="angiotensin II" preferredWord="Angiotensin II" semType="bacs, phsu, aapp"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="157:178" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.72.e.10" text="potassium supplements" type="Drug_Class"><Normalization><mmtx cui="C0304475" phraseText="potassium supplements," preferredWord="Potassium supplement" semType="inch, phsu"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="183:220" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.72.e.11" text="salt substitutes containing potassium" type="Substance"><Normalization><mmtx cui="C0784217" phraseText="salt substitutes" preferredWord="Salt Substitute" semType="inch, phsu"/><mmtx cui="C0597277" phraseText="potassium" preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="9547"/></Normalization></entity><drugClassMembership drug="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.72.e.2" drugClass="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.72.e.1"/><drugClassMembership drug="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.72.e.4" drugClass="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.72.e.1"/><drugClassMembership drug="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.72.e.6" drugClass="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.72.e.1"/><drugInteraction id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.72.ddi.1"><interaction trigger="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.72.e.8"><relations><relation type="hasObject"><entity id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.72.e.9"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.72.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.72.e.10"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.72.e.11"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.72.e.9" e2="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.72.e.1" trigger="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.72.e.8" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.72.e.9" e2="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.72.e.10" trigger="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.72.e.8" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.72.e.9" e2="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.72.e.11" trigger="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.72.e.8" type="Specific_Interaction"/><pair ddi="false" e1="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.72.e.1" e2="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.72.e.10"/><pair ddi="false" e1="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.72.e.1" e2="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.72.e.11"/><pair ddi="false" e1="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.72.e.10" e2="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.72.e.11"/></sentence><sentence biomedicalEntities="2" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.73" lineNumber="66" text="Lithium: As with other drugs which affect the excretion of sodium, lithium excretion may be reduced. " type="regular"><entity charOffset="75:99" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.73.e.1" text="excretion may be reduced" type="Increase_Interaction"/><entity charOffset="67:74" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.73.e.2" text="lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="lithium excretion" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><entity charOffset="23:65" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.73.e.3" text="drugs which affect the excretion of sodium" type="Drug_Class"><Normalization><mmtx cui="C0013227" phraseText="As with other drugs" preferredWord="Pharmaceutical Preparations" semType="phsu"/><mmtx cui="C0597484" phraseText="the excretion of sodium," preferredWord="Sodium Cation" semType="phsu, elii"/><RxNorm RxCui="NA"/></Normalization></entity><drugInteraction id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.73.ddi.1"><interaction trigger="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.73.e.1"><relations><relation type="hasObject"><entity id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.73.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.73.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.73.e.3" e2="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.73.e.2" trigger="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.73.e.1" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.74" lineNumber="66" text="Therefore, serum lithium levels should be monitored carefully if lithium salts are to be co-administered with angiotensin II receptor antagonists." type="regular"><anaphoraRelation><anaphoraEntity charOffset="65:78" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.74.e.5" text="lithium salts" type="Drug"/><antecedentEntity charOffset="17-24" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.74.e.2" text="lithium" type="Drug"/></anaphoraRelation><entity charOffset="42:51" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.74.e.1" text="monitored" type="Caution_Interaction"/><entity charOffset="17:24" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.74.e.2" text="lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="serum lithium levels" preferredWord="Lithium" semType="phsu, elii"/><mmtx cui="C0023870" phraseText="serum lithium levels" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><entity charOffset="110:145" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.74.e.3" text="angiotensin II receptor antagonists" type="Drug_Class"><Normalization><mmtx cui="C0521942" phraseText="co-administered with angiotensin II receptor antagonists." preferredWord="Angiotensin II receptor antagonist" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="65:78" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.74.e.5" text="lithium salts" type="Drug"><Normalization><mmtx cui="C0302213" phraseText="lithium salts" preferredWord="Lithium salt" semType="inch, phsu"/><RxNorm RxCui="1428998"/></Normalization></entity><drugInteraction id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.74.ddi.1"><interaction trigger="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.74.e.1"><relations><relation type="hasObject"><entity id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.74.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.74.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.74.e.2" e2="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.74.e.3" trigger="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.74.e.1" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="4" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.75" lineNumber="67" text="Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Including Selective Cyclooxygenase-2 Inhibitors (COX-2 Inhibitors): In patients who are elderly, volume-depleted (including those on diuretic therapy), or with compromised renal function, co-administration of NSAIDs, including selective COX-2 inhibitors, with angiotensin II receptor antagonists (including losartan) may result in deterioration of renal function, including possible acute renal failure. " type="regular"><entity charOffset="307:342" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.75.e.1" text="angiotensin II receptor antagonists" type="Drug_Class"><Normalization><mmtx cui="C0521942" phraseText="with angiotensin II receptor antagonists" preferredWord="Angiotensin II receptor antagonist" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="354:362" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.75.e.2" text="losartan" type="Drug"><Normalization><mmtx cui="C0126174" phraseText="losartan" preferredWord="Losartan" semType="phsu, orch"/><RxNorm RxCui="52175"/></Normalization></entity><entity charOffset="378:409" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.75.e.4" text="deterioration of renal function" type="Specific_Interaction"/><entity charOffset="207:233" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.75.e.5" text="compromised renal function" type="SPAN"/><entity charOffset="256:262" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.75.e.6" text="NSAIDs" type="Drug_Class"><Normalization><mmtx cui="C3536840" phraseText="co-administration of NSAIDs," preferredWord="Nonsteroidal Anti-inflammatory Drug [EPC]" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><entity charOffset="135:142" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.75.e.7" text="elderly" type="SPAN"/><entity charOffset="144:159" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.75.e.8" text="volume-depleted" type="SPAN"/><entity charOffset="274:300" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.75.e.10" text="selective COX-2 inhibitors" type="Drug_Class"><Normalization><mmtx cui="C1257954" phraseText="selective COX-2 inhibitors," preferredWord="Cyclooxygenase 2 Inhibitors" semType="phsu, orch"/><RxNorm RxCui="1431714"/></Normalization></entity><entity charOffset="430:449" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.75.e.12" text="acute renal failure" type="Specific_Interaction"><Normalization><mmtx cui="C0022660" phraseText="possible acute renal failure." preferredWord="Kidney Failure, Acute" semType="dsyn"/></Normalization></entity><drugClassMembership drug="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.75.e.2" drugClass="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.75.e.1"/><classClassMembership drugClass="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.75.e.10"/><drugInteraction id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.75.ddi.1"><interaction trigger="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.75.e.4"><relations><relation type="hasContext"><entity id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.75.e.5"/></relation><relation type="hasObject"><entity id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.75.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.75.e.6"/></relation><relation type="hasContext"><entity id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.75.e.7"/></relation><relation type="hasContext"><entity id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.75.e.8"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.75.ddi.2"><interaction trigger="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.75.e.12"><relations><relation type="hasContext"><entity id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.75.e.5"/></relation><relation type="hasObject"><entity id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.75.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.75.e.6"/></relation><relation type="hasContext"><entity id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.75.e.7"/></relation><relation type="hasContext"><entity id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.75.e.8"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.75.e.5, Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.75.e.7, Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.75.e.8" ddi="true" e1="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.75.e.6" e2="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.75.e.1" trigger="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.75.e.4" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.77" lineNumber="67" text="Monitor renal function periodically in patients receiving losartan and NSAID therapy." type="regular"><entity charOffset="0:7" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.77.e.1" text="Monitor" type="Caution_Interaction"/><entity charOffset="58:66" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.77.e.2" text="losartan" type="Drug"><Normalization><mmtx cui="C0126174" phraseText="losartan" preferredWord="Losartan" semType="phsu, orch"/><RxNorm RxCui="52175"/></Normalization></entity><entity charOffset="71:84" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.77.e.3" text="NSAID therapy" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="NSAID therapy." preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><drugInteraction id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.77.ddi.1"><interaction trigger="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.77.e.1"><relations><relation type="hasObject"><entity id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.77.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.77.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.77.e.2" e2="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.77.e.3" trigger="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.77.e.1" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="4" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.78" lineNumber="68" text="The antihypertensive effect of angiotensin II receptor antagonists, including losartan, may be attenuated by NSAIDs, including selective COX-2 inhibitors." type="regular"><entity charOffset="31:66" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.78.e.1" text="angiotensin II receptor antagonists" type="Drug_Class"><Normalization><mmtx cui="C0521942" phraseText="The antihypertensive effect of angiotensin II receptor antagonists," preferredWord="Angiotensin II receptor antagonist" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="78:86" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.78.e.2" text="losartan" type="Drug"><Normalization><mmtx cui="C0126174" phraseText="losartan," preferredWord="Losartan" semType="phsu, orch"/><RxNorm RxCui="52175"/></Normalization></entity><entity charOffset="109:115" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.78.e.4" text="NSAIDs" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="attenuated by NSAIDs," preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><entity charOffset="127:153" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.78.e.5" text="selective COX-2 inhibitors" type="Drug_Class"><Normalization><mmtx cui="C1257954" phraseText="selective COX-2 inhibitors." preferredWord="Cyclooxygenase 2 Inhibitors" semType="phsu, orch"/><RxNorm RxCui="1431714"/></Normalization></entity><entity charOffset="4:27|88:105" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.78.e.7" text="antihypertensive effect may be attenuated" type="Specific_Interaction"/><drugClassMembership drug="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.78.e.2" drugClass="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.78.e.1"/><classClassMembership drugClass="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.78.e.5"/><drugInteraction id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.78.ddi.1"><interaction trigger="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.78.e.7"><relations><relation type="hasObject"><entity id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.78.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.78.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.78.e.1" e2="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.78.e.4" trigger="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.78.e.7" type="Specific_Interaction"/></sentence><sentence id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.97" text="Antihypertensive effects of losartan potassium tablets have been established in hypertensive pediatric patients aged 6 to 16 years. " type="negative"><entity charOffset="28:46" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.97.e.0" text="losartan potassium" type="Biomedical_Entity"><Normalization><mmtx cui="C0700492" phraseText="Antihypertensive effects of losartan potassium tablets" preferredWord="Losartan Potassium" semType="phsu, orch"/><RxNorm RxCui="52175"/></Normalization></entity><entity charOffset="0:16" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.97.e.1" text="antihypertensive" type="Biomedical_Entity"><Normalization><mmtx cui="C0003364" phraseText="Antihypertensive effects of losartan potassium tablets" preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><pair ddi="false" e1="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.97.e.1" e2="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.97.e.0"/></sentence><sentence id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.98" text="There are no data on the effect of losartan potassium tablets on blood pressure in pediatric patients under the age of 6 or in pediatric patients with glomerular filtration rate 30 mL/min/1.73 m2 (see CLINICAL PHARMACOLOGY, Pharmacokinetics, Special Populations and Pharmacodynamics and Clinical Effects, and DOSAGE AND ADMINISTRATION)." type="negative"><entity charOffset="10:17" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.98.e.0" text="no data" type="Biomedical_Entity"><Normalization><mmtx cui="C1572381" phraseText="no data on the effect of losartan potassium tablets" preferredWord="No Data re: Ingredient" semType="phsu"/><RxNorm RxCui="53704"/></Normalization></entity><entity charOffset="35:53" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.98.e.1" text="losartan potassium" type="Biomedical_Entity"><Normalization><mmtx cui="C0700492" phraseText="no data on the effect of losartan potassium tablets" preferredWord="Losartan Potassium" semType="phsu, orch"/><RxNorm RxCui="52175"/></Normalization></entity><pair ddi="false" e1="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.98.e.0" e2="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.98.e.1"/></sentence><sentence id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.105" text="In the LIFE study, Black patients with hypertension and left ventricular hypertrophy had a lower risk of stroke on atenolol than on losartan potassium tablets. " type="negative"><entity charOffset="115:123" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.105.e.0" text="atenolol" type="Biomedical_Entity"><Normalization><mmtx cui="C0004147" phraseText="on atenolol" preferredWord="Atenolol" semType="phsu, orch"/><RxNorm RxCui="1202"/></Normalization></entity><entity charOffset="132:150" id="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.105.e.1" text="losartan potassium" type="Biomedical_Entity"><Normalization><mmtx cui="C0700492" phraseText="on losartan potassium tablets." preferredWord="Losartan Potassium" semType="phsu, orch"/><RxNorm RxCui="52175"/></Normalization></entity><pair ddi="false" e1="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.105.e.0" e2="Dailymed.46c2cb4b-eb65-45f5-891f-5e574adc962d.s.105.e.1"/></sentence><positiveExamples number="17"/><negativeExamples number="38"/></document>